Remove 2017 Remove Generic Medicine Remove Labelling
article thumbnail

DIA’s India Annual Meeting to host discussions on evolving regulatory landscape

Express Pharma

The safety of nanoparticles, complexities surrounding medicolegal cases, and long-acting formulations like implants in bioavailability and bioequivalence studies will also be discussed. ” Now in its 11th year, the India Annual Meeting enables attendees to interact, network, and debate the most pressing issues facing the life sciences.

article thumbnail

Complex generics: Are global regulators addressing the needs?

Quality Matters

Complex generics: Are global regulators addressing the needs? The development of generic versions of innovator medicines is a global public health need. Quality standards in particular help ensure medicines are safe, work as intended, and are available when needed, no matter the company producing them or where they are made.

Dosage 52
article thumbnail

Essential elements of a strong, global medicines supply chain

Quality Matters

Essential elements of a strong, global medicines supply chain The U.S. Pharmacopeia (USP) has long been recognized as an international leader in medicines quality and supply chain integrity. Adherence to standards facilitates a supply of medicines with consistent quality, no matter which company produces them or where they are made.